Big deal
Golly gee whiz, the FDA approved the first new type of anti-depressant in 60 years! The below article reports it reduces symptoms a whopping five percent more than a placebo. What it doesn’t say is how long it’s gonna work for someone or what side effects are over the long term. Honestly, does that sound like something to sign up for?—MR
FDA OKs First Oral NMDA Receptor Antagonist for Depression
by Kristen Monaco, MedPage Today, August 19, 2022
The FDA approved combination dextromethorphan and bupropion extended-release tablets (Auvelity) for adults with major depressive disorder (MDD), Axsome Therapeutics announced on Friday.
